title: Infantile hemangiomas: an update.
abstract: Infantile hemangioma (IH) is a common vascular tumor of infancy. Although benign, infants with IH can experience complications including ulceration, visual and airway impairment, and residual scarring and disfigurement. It is often challenging for clinicians to predict which tumors are in need of systemic treatment. However, data from various demographic and other studies have revealed further insights into this tumor. This article reviews the identification, evaluation, and management of high-risk IHs, including the indications for treatment and the use of systemic treatments such as corticosteroids, β-blockers, and vincristine.
authors: Department of Dermatology, Medical College of Wisconsin, 8701 Watertown Plank Road, TBRC, 2nd Floor, Suite C2010, Milwaukee, WI 53226, USA.
authors: Eun-Kyung Mary
authors: EK
authors: Kwon
authors: Marcia
authors: M
authors: Seefeldt
authors: Beth A
authors: BA
authors: Drolet
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001707:Biopsy, Needle; D003131:Combined Modality Therapy; D062109:Dermatologic Surgical Procedures / Q000379:methods; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006391:Hemangioma / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D016898:Interferon-alpha / Q000627:therapeutic use; D028022:Low-Level Light Therapy / Q000379:methods; D008297:Male; D011433:Propranolol / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D016898:Interferon-alpha; D014750:Vincristine; D011433:Propranolol